☆ 4.6 Article

Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls

FRONTIERS IN GENETICS (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021

Mary B. Daly et al.

Summary: The NCCN Guidelines focus on assessing genetic variants associated with increased risk of breast, ovarian, and pancreatic cancer, particularly BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome. Individuals with pathogenic BRCA1/2 variants have high risks of breast and ovarian cancer, as well as elevated risks of prostate cancer and pancreatic cancer. Li-Fraumeni syndrome is associated with high lifetime risks of various cancers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Add to Collection

Article Medicine, General & Internal

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu et al.

Summary: This study provides population-based estimates of the prevalence and risk of breast cancer associated with pathogenic variants in known cancer-predisposition genes. The results highlight the varying levels of risk associated with different genes, such as high risk for BRCA1 and BRCA2 and moderate risk for PALB2, as well as associations with specific subtypes of breast cancer for genes like RAD51C and RAD51D.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

Leila Dorling et al.

Summary: This study sequenced samples from 60,466 women with breast cancer and 53,461 controls using a panel of 34 putative susceptibility genes, identifying associations between protein-truncating variants in certain genes and breast cancer risk. The results provide important information for genetic counseling and define genes that are most clinically useful for predicting breast cancer risk.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing

Melissa C. Southey et al.

Summary: Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing are urgently required. Our findings provide a population-based perspective to gene-panel testing for breast cancer predisposition and opportunities to improve predictors for identifying women who carry pathogenic variants in breast cancer predisposition genes.

NPJ BREAST CANCER (2021)

Add to Collection

Article Genetics & Heredity

An updated quantitative model to classify missense variants in the TP53 gene: A novel multifactorial strategy

Cristina Fortuno et al.

Summary: The development of a new model for classifying TP53 gene variants, along with the addition of new evidence, has proven to be effective in resolving conflicting and uncertain classifications. This model can contribute to optimizing TP53-specific ACMG/AMP guidelines.

HUMAN MUTATION (2021)

Add to Collection

Article Oncology

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer

Siddhartha Yadav et al.

Summary: The study evaluated the racial and ethnic differences in prevalence of germline pathogenic variants among breast cancer patients, suggesting a need for personalized management of breast cancer risk based on race and ethnicity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Article Oncology

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Review Oncology

Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers

Giulia Federici et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Oncology

NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases

Maria Zanti et al.

CANCERS (2020)

Add to Collection

Article Genetics & Heredity

A quantitative model to predict pathogenicity of missense variants in the TP53 gene

Cristina Fortuno et al.

HUMAN MUTATION (2019)

Add to Collection

Review Oncology

State-of-the-art strategies for targeting the DNA damage response in cancer

Patrick G. Pilie et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection

Article Genetics & Heredity

BRCA1 and BRCA2 mutation testing in Cyprus; a population based study

M. A. Loizidou et al.

CLINICAL GENETICS (2017)

Add to Collection

Article Medicine, General & Internal

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Article Oncology

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes

Saundra S. Buys et al.

CANCER (2017)

Add to Collection

Article Oncology

Age- and Tumor Subtype Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

Marjanka K. Schmidt et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Oncology

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

Nadine Tung et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Genetics & Heredity

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards et al.

GENETICS IN MEDICINE (2015)

Add to Collection

Article Oncology

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

Cezary Cybulski et al.

LANCET ONCOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

Elise Ruark et al.

NATURE (2013)

Add to Collection

Article Genetics & Heredity

ENIGMA-Evidence-Based Network for the Interpretation of Germline Mutant Alleles: An International Initiative to Evaluate Risk and Clinical Significance Associated with Sequence Variation in BRCA1 and BRCA2 Genes

Amanda B. Spurdle et al.

HUMAN MUTATION (2012)

Add to Collection

Article Oncology

An investigation of breast cancer risk factors in Cyprus: a case control study

Andreas Hadjisavvas et al.

BMC CANCER (2010)

Add to Collection

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

Add to Collection

Article Oncology

Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus

Maria A. Loizidou et al.

BREAST CANCER RESEARCH AND TREATMENT (2008)

Add to Collection

Article Oncology

Hereditary breast and ovarian cancer in Cyprus:: identification of a founder BRCA2 mutation

A Hadjisavvas et al.

CANCER GENETICS AND CYTOGENETICS (2004)

Add to Collection

Article Genetics & Heredity

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies

A Antoniou et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.